PKI @JPM: Neonatal screening currently a $250M global market—potential $1B if emerging markets were to average 10 assays per child (vs 30 currently in US).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”